Sirton Pharmaceuticals Overview
- Year Founded
-
1944
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
Sirton Pharmaceuticals General Information
Description
Operator of a pharmaceutical contract manufacturing company intended to serve the healthcare sector. The company produces injectable pharma products, including pre-filled syringes, liquid vials, freeze-dried vials and ampoules and provides pharmaceutical development services including lyophilization process development, analytical method development and validation, stability studies and manufacturing of clinical study materials, thereby enabling clients with precise products as per their requirements.
Contact Information
Website
www.sirton.it
Formerly Known As
Crinos Industria Farmacobiologica
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Office
- Piazza XX Settembre, 2
- 22079 Villa Guardia
- Italy
+39 031 000000
Sirton Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sirton Pharmaceuticals Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Matteo Bartalena | Chief Executive Officer and Chief Financial Officer | ||
| Andrea Balzano | Chief Operating Officer | ||
| Jing Lou Ph.D | President |
Sirton Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|